Identifying dose constraints for the parotid ducts to minimize patient‐reported xerostomia: Is conventional mean dose sparing of the parotid glands sufficient?
Parotid duct dose thresholds exist that appear to distinguish patients with and without xerostomia. The identified dose thresholds are frequently not met in PGS-RT plans. In addition to reducing the dose to the parotid gland(s), parotid duct sparing may also further reduce xerostomia.
Authors
- Tong Zhu (ORCID: https://orcid.org/0000-0002-9305-458X)
- David Fried (ORCID: https://orcid.org/0000-0003-2249-8025)
- Bhishamjit S. Chera (ORCID: https://orcid.org/0000-0002-6775-7986)
- Manal Ahmidouch
- Colette Shen
- Shiva K. Das
- L.B. Marks
Institutions
- University of North Carolina at Chapel Hill (US)
- Medical University of South Carolina (US)
- Washington University in St. Louis (US)
Publication Details
- Journal
- Journal of Applied Clinical Medical Physics
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1002/acm2.14515
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00